These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29793671)

  • 21. What happens to the heart in chronic kidney disease?
    Rutherford E; Mark PB
    J R Coll Physicians Edinb; 2017 Mar; 47(1):76-82. PubMed ID: 28569289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation.
    Fleming I
    Trends Pharmacol Sci; 2007 Sep; 28(9):448-52. PubMed ID: 17764757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.
    Liao J; Hwang SH; Li H; Liu JY; Hammock BD; Yang GY
    Anticancer Res; 2016 Jan; 36(1):27-37. PubMed ID: 26722025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of inflammation on cardiovascular protective effects of cytochrome P450 epoxygenase-derived epoxyeicosatrienoic acids.
    Shahabi P; Siest G; Visvikis-siest S
    Drug Metab Rev; 2014 Feb; 46(1):33-56. PubMed ID: 24040964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EETs/sEH in diabetes and obesity-induced cardiovascular diseases.
    Huang H; Weng J; Wang MH
    Prostaglandins Other Lipid Mediat; 2016 Sep; 125():80-9. PubMed ID: 27184755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
    Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-Palmitoylethanolamide protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress.
    Mattace Raso G; Simeoli R; Russo R; Santoro A; Pirozzi C; d'Emmanuele di Villa Bianca R; Mitidieri E; Paciello O; Pagano TB; Orefice NS; Meli R; Calignano A
    Pharmacol Res; 2013 Oct; 76():67-76. PubMed ID: 23917217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases.
    Zordoky BN; El-Kadi AO
    Pharmacol Ther; 2010 Mar; 125(3):446-63. PubMed ID: 20093140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epoxyeicosatrienoic acids--novel mechanism and pharmacological therapy of chronic renocardiac syndrome.
    Huang H; Chen J; Lin T; Wang T; Tang Y; Dong Y; Wang J
    Med Hypotheses; 2011 Apr; 76(4):550-2. PubMed ID: 21333454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
    Dalle Vedove F; Fava C; Jiang H; Zanconato G; Quilley J; Brunelli M; Guglielmi V; Vattemi G; Minuz P
    J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.
    Zhao X; Yamamoto T; Newman JW; Kim IH; Watanabe T; Hammock BD; Stewart J; Pollock JS; Pollock DM; Imig JD
    J Am Soc Nephrol; 2004 May; 15(5):1244-53. PubMed ID: 15100364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-based optimization of cyclopropyl urea derivatives as potent soluble epoxide hydrolase inhibitors for potential decrease of renal injury without hypotensive action.
    Takai K; Nakajima T; Takanashi Y; Sone T; Nariai T; Chiyo N; Nakatani S; Ishikawa C; Yamaguchi N; Fujita K; Yamada K
    Bioorg Med Chem; 2014 Mar; 22(5):1548-57. PubMed ID: 24530032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasopressin lowers renal epoxyeicosatrienoic acid levels by activating soluble epoxide hydrolase.
    Boldt C; Röschel T; Himmerkus N; Plain A; Bleich M; Labes R; Blum M; Krause H; Magheli A; Giesecke T; Mutig K; Rothe M; Weldon SM; Dragun D; Schunck WH; Bachmann S; Paliege A
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1198-F1210. PubMed ID: 27681558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of protein carbamylation in chronic kidney disease complications].
    Gillery P; Jaisson S; Gorisse L; Pietrement C
    Nephrol Ther; 2015 Jun; 11(3):129-34. PubMed ID: 25794932
    [TBL] [